Navigation Links
U of M study: Health food supplement may curb addiction of pathological gamblers
Date:9/11/2007

MINNEAPOLIS/ ST. PAUL (Sept. 11, 2007) University of Minnesota researchers have discovered that a common amino acid, available as a health food supplement, may help curb pathological gamblers addiction.

In a recent eight-week trial, 27 people were given increasing doses of the amino acid, N-acetyl cysteine, which has an impact on the chemical glutamate often associated with reward in the brain. At the end of the trial, 60 percent of the participants reported fewer urges to gamble. The research will be published in the Sept.15, 2007 issue of Biological Psychiatry.

It looks very promising, said Jon Grant, J.D., M.D., a University of Minnesota associate professor of psychiatry and principal investigator of the study. We were able to reduce peoples urges to gamble.

Those who responded well in the first round of the study were asked to continue to participate in a double-blind study a testing method where neither the researcher nor subjects know who is in the control group until the study is finished.

Of the 16 who responded to the amino acid the first time around, 13 agreed to continue in the double-blind study (three didnt want to risk quitting the drug) for an additional six weeks. About 83 percent who received the supplement, continued to report fewer urges to gamble. Nearly 72 percent of those who took the placebo went back to gambling.

Similar studies using N-acetyl cysteine have shown its ability to curb drug addictions in animals, and a current University of Minnesota study conducted by Grant is investigating whether the drug could help methamphetamine users quit.

This research could be encouraging for a lot of addictions, Grant said.

This pilot study is the first to examine the efficacy of a glutamate-modulating agent in the treatment of pathological gamblers, making the findings fairly significant, Grant said.

Because subjects knew they were taking a supplement during the first phase of the study and since there was a relatively small number of subjects in the double-blind portion, a larger study is warranted to confirm the validity of these findings. University of Minnesota researchers are currently seeking a federal grant to fund it.


'/>"/>

Contact: Nick Hanson
hans2853@umn.edu
612-624-2449
University of Minnesota
Source:Eurekalert

Related medicine news :

1. Counter study: cholesterol drugs no good in preventing colon cancer
2. A strategic study: Soy diet makes heart disease to worsen in male mice
3. Bird Flu Pandemic Study: Clerical & Support Staff May Stay At Home
4. Study: Older Pancreatic Cancer Surgery Survivors Live Long
5. New Study: Pine Bark Significantly Reduces Endometriosis
6. Poor health care in Russia maybe causing Decline in its Population
7. Startling Expose – Physicians Often Have No Regular Source Of Health Car
8. Debate Rages over firing of HIV infected health care workers
9. Want a Healthy brew? Have some Tea!
10. Patient’s perception of health status helps in better recover
11. Antioxidants protect health tissue in people undergoing radiation therapy.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: